Clinical Trial Update: Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating biomarkers in women receiving chemotherapy with celecoxib for stage II/III breast cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University of Nebraska | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-07-10